BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/20/2026 7:08:29 AM | Browse: 3 | Download: 5
 |
Received |
|
2025-12-18 01:43 |
|
Peer-Review Started |
|
2025-12-18 01:44 |
|
First Decision by Editorial Office Director |
|
2026-01-22 07:59 |
|
Return for Revision |
|
2026-01-22 07:59 |
|
Revised |
|
2026-02-03 15:14 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-04-21 02:51 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-04-21 08:06 |
|
Articles in Press |
|
2026-04-21 08:06 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-06 03:05 |
|
Publish the Manuscript Online |
|
2026-07-20 07:08 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Editorial |
| Article Title |
NeoHexa stent at five years: Sirolimus power meets real-world endurance
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ji-Xin Zhong and Xiao-Quan Rao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the National Key Research and Development Program of China |
No. 2023YFC2507902 and No. 2022YFA1105303 |
| National Natural Science Foundation of China |
No. 82572075, No. 82270903, and No. 82370465 |
| Hubei Key R and D Project |
No. 2023BCB013 |
|
| Corresponding Author |
Ji-Xin Zhong, Chief Physician, Director, MD, PhD, Principal Investigator, Professor, Department of Rheumatology, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, Fujian Province, China. zhongjixin620@163.com |
| Key Words |
Stent; Safety; Outcome; Cardiovascular disease; Sirolimus-eluting stent |
| Core Tip |
The retrospective study by Trehan et al provides critical five-year real-world evidence for the NeoHexa sirolimus-eluting stent, demonstrating exceptional long-term durability in a complex, all-comer patient population. With a remarkably low rate of major adverse cardiac events and target lesion revascularization, the findings underscore the stent's sustained safety and efficacy. |
| Publish Date |
2026-07-20 07:08 |
| Citation |
Zhong JX, Rao XQ. NeoHexa stent at five years: Sirolimus power meets real-world endurance. World J Cardiol 2026; 18(7): 117872
|
| URL |
https://www.wjgnet.com/1949-8462/full/v18/i7/117872.htm |
| DOI |
https://doi.org/10.4330/wjc.117872 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
